Research programme: central nervous system disorder therapeutics - Johnson & Johnson Innovation/Peking UniversityAlternative Names: G-protein-coupled receptors (GPCRs) agonists and antagonists - Johnson and Johnson Innovation/Peking University
Latest Information Update: 04 Nov 2014
At a glance
- Originator Johnson & Johnson Innovation; Peking University
- Mechanism of Action G protein-coupled receptor agonists; G protein-coupled receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 28 Oct 2014 Early research in CNS disorders in China (unspecified route)